Watching
$Coherus BioSciences(CHRS.US$ im watching closely for this ( Coherus anticipates demand will continue to rise with significantly improved commercial and Medicare Advantage formulary coverage in the fourth quarter of 2023 and in 2024.)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Khayfoong : why this terrible drop?
Trytosaveabit OP Khayfoong : Earnings was bad! They cut their guidance for next year and analysts cut the PT almost by half! GL
Khayfoong : gg